NCT03808844View on ClinicalTrials.gov

A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion for the Induction of General Anesthesia in Elective Surgery Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

March 22, 2019

Primary Completion Date

August 14, 2019

Study Completion Date

September 3, 2019

Conditions
Induction of Anesthesia
Interventions
DRUG

HSK3486

Initial dose of 0.4 mg/kg followed by 0.2 mg/kg if needed.

DRUG

Propofol

Initial dose of 2.0 mg/kg followed by 1.0 mg/kg if needed

Trial Locations (1)

Unknown

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors
lead

Sichuan Haisco Pharmaceutical Group Co., Ltd

INDUSTRY

NCT03808844 - A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion for the Induction of General Anesthesia in Elective Surgery Subjects | Biotech Hunter | Biotech Hunter